These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26929045)

  • 1. A survey of Australian and New Zealand clinical practice with neoadjuvant systemic therapy for breast cancer.
    Zdenkowski N; Butow P; Mann GB; Fewster S; Beckmore C; Isaacs R; Douglas C; Boyle FM
    Intern Med J; 2016 Jun; 46(6):677-83. PubMed ID: 26929045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported outcomes with neoadjuvant vs adjuvant systemic therapy for operable breast cancer.
    Zdenkowski N; Butow P; Spillane A; Douglas C; Snook K; Jones M; Oldmeadow C; Fewster S; Beckmore C; Boyle FM
    Breast; 2019 Aug; 46():25-31. PubMed ID: 31059987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ever-evolving role of pathologists in the management of breast cancer with neoadjuvant treatment: recommendations based on the Spanish clinical experience.
    Burgués O; López-García MÁ; Pérez-Míes B; Santiago P; Vieites B; García JF; Peg V
    Clin Transl Oncol; 2018 Mar; 20(3):382-391. PubMed ID: 28795336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decisions about neoadjuvant systemic therapy for breast cancer: a survey of Australian and New Zealand specialists.
    Zdenkowski N; Butow P; Mann B; Fewster S; Douglas C; Boyle FM
    ANZ J Surg; 2015 Nov; 85(11):797-8. PubMed ID: 26798858
    [No Abstract]   [Full Text] [Related]  

  • 5. Single-Arm Longitudinal Study to Evaluate a Decision Aid for Women Offered Neoadjuvant Systemic Therapy for Operable Breast Cancer.
    Zdenkowski N; Butow P; Spillane A; Douglas C; Snook K; Jones M; Oldmeadow C; Fewster S; Beckmore C; Boyle FM;
    J Natl Compr Canc Netw; 2018 Apr; 16(4):378-385. PubMed ID: 29632057
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast interest group faculty of radiation oncology: Australian and New Zealand patterns of practice survey on breast radiotherapy.
    Nguyen K; Mackenzie P; Allen A; Dreosti M; Morgia M; Zissiadis Y; Lamoury G; Windsor A
    J Med Imaging Radiat Oncol; 2017 Aug; 61(4):508-516. PubMed ID: 27987274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women's Experiences with Deciding on Neoadjuvant Systemic Therapy for Operable Breast Cancer: A Qualitative Study.
    Herrmann A; Hall A; Zdenkowski N
    Asia Pac J Oncol Nurs; 2018; 5(1):68-76. PubMed ID: 29379837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept.
    Pfob A; Cai L; Schneeweiss A; Rauch G; Thomas B; Schaefgen B; Kuemmel S; Reimer T; Hahn M; Thill M; Blohmer JU; Hackmann J; Malter W; Bekes I; Friedrichs K; Wojcinski S; Joos S; Paepke S; Degenhardt T; Rom J; Rody A; van Mackelenbergh M; Banys-Paluchowski M; Große R; Reinisch M; Karsten MM; Sidey-Gibbons C; Wallwiener M; Golatta M; Heil J
    Ann Surg Oncol; 2024 Feb; 31(2):957-965. PubMed ID: 37947974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of practice in the management of prostate cancer: results from multidisciplinary surveys of clinicians in Australia and New Zealand in 1995 and 2000.
    Chong CC; Austen L; Kneebone A; Lalak A; Jalaludin B
    BJU Int; 2006 May; 97(5):975-80. PubMed ID: 16542341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring women's experiences with a decision aid for neoadjuvant systemic therapy for operable breast cancer.
    Herrmann A; Boyle F; Butow P; Hall AE; Zdenkowski N
    Health Sci Rep; 2018 Jan; 1(1):e13. PubMed ID: 30623032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The underused potential of breast conserving therapy after neoadjuvant system treatment - Causes and solutions.
    Pfob A; Dubsky P
    Breast; 2023 Feb; 67():110-115. PubMed ID: 36669994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant systemic therapy in geriatric breast cancer patients: a National Cancer Database (NCDB) analysis.
    Brown L; Naffouje SA; Sam C; Laronga C; Catherine Lee M
    Breast Cancer Res Treat; 2022 Dec; 196(3):441-451. PubMed ID: 36207620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand.
    Rajadevan N; Flinkier A; Saunders H; Lee YC; Scott C; Khaw P; Allan P; Davies C; Andrews J; Wilson M; Lombard JM; Harrison M; Nesfield H; DeFazio A; Meniawy T; Gorringe KL
    Aust N Z J Obstet Gynaecol; 2024 Aug; 64(4):319-325. PubMed ID: 38299485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can multi-modal radiomics using pretreatment ultrasound and tomosynthesis predict response to neoadjuvant systemic treatment in breast cancer?
    Cai L; Sidey-Gibbons C; Nees J; Riedel F; Schäfgen B; Togawa R; Killinger K; Heil J; Pfob A; Golatta M
    Eur Radiol; 2024 Apr; 34(4):2560-2573. PubMed ID: 37707548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment recommendations for older women with breast cancer: A survey among surgical, radiation and medical oncologists.
    Hamelinck VC; Stiggelbout AM; van de Velde CJH; Liefers GJ; Bastiaannet E
    Eur J Surg Oncol; 2017 Jul; 43(7):1288-1296. PubMed ID: 28258786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rates of Neoadjuvant Chemotherapy and Oncoplastic Surgery for Breast Cancer Surgery: A French National Survey.
    Clough KB; Acosta-Marín V; Nos C; Alran S; Rouanet P; Garbay JR; Giard S; Verhaeghe JL; Houvenaeghel G; Flipo B; Dauplat J; Dorangeon PH; Classe JM; Rouzier R; Bonnier P
    Ann Surg Oncol; 2015 Oct; 22(11):3504-11. PubMed ID: 25665949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to Clinical Trial Accrual: Perspectives of Community-Based Providers.
    Knelson LP; Cukras AR; Savoie J; Agarwal A; Guo H; Hu J; Fell G; Lederman R; Hughes ME; Winer EP; Lin NU; Tolaney SM
    Clin Breast Cancer; 2020 Oct; 20(5):395-401.e3. PubMed ID: 32605813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Molecular Methods in Drug Development: Neoadjuvant Systemic Therapy in Breast Cancer as a Model.
    Braga S
    Methods Mol Biol; 2016; 1395():251-80. PubMed ID: 26910079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks.
    Buchholz TA; Hunt KK; Whitman GJ; Sahin AA; Hortobagyi GN
    Cancer; 2003 Sep; 98(6):1150-60. PubMed ID: 12973838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer.
    Read RL; Flitcroft K; Snook KL; Boyle FM; Spillane AJ
    ANZ J Surg; 2015 May; 85(5):315-20. PubMed ID: 25612239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.